Definium Therapeutics
DFTX
NASDAQ
Biotech
Markets openAuto-updating · last checked
Neuropsychiatric drug developer working on next-generation treatments for mood disorders.
12-month trend
Fundamentals
Revenue, earnings and balance-sheet data for DFTX, updated as each quarter is reported.
Recent news
- Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX), Sarepta ...theglobeandmail.com
- Definium Therapeutics Investors Remain Concerned Over Psychedelics ' Commercial ...finance.yahoo.com
- Definium Therapeutics Investors Remain Concerned Over Psychedelics ' Commercial ...moomoo.com
- Definium Therapeutics Investors Remain Concerned Over Psychedelics ' Commercial ...marketscreener.com
- Definium Therapeutics Announces New Employee Inducement Grants - The Globe and Mailtheglobeandmail.com
- Why is Definium Therapeutics stock gaining today? - Investing.cominvesting.com